Polypoidal Choroidal Vasculopathy: Recent advances in therapy

G. de Crecchio, R. V P Chan, G. Manzi, M. R. Romano

Research output: Contribution to journalArticle

Abstract

Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.

Original languageEnglish
Pages (from-to)206-211
Number of pages6
JournalCurrent Drug Targets
Volume12
Issue number2
DOIs
Publication statusPublished - Jul 2012

Keywords

  • Age-related macular degeneration
  • AntiVEGF
  • Choroidal neovascularization
  • Combination therapy
  • Photodynamic therapy
  • Polypoidal choroidal vasculopathy
  • Triamcinolone

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Polypoidal Choroidal Vasculopathy: Recent advances in therapy'. Together they form a unique fingerprint.

  • Cite this

    de Crecchio, G., Chan, R. V. P., Manzi, G., & Romano, M. R. (2012). Polypoidal Choroidal Vasculopathy: Recent advances in therapy. Current Drug Targets, 12(2), 206-211. https://doi.org/10.2174/138945011794182782